Bupivacaine Hydrochloride-EPINEPHrine
Phase 1Small molecule
Bupivacaine Hydrochloride-EPINEPHrine is one of 9 small molecule programs targeting Opioid. It is currently in Phase 1.
1
Indications
1
Total Trials
1
Active Trials
8
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
11 competitors in Opioid
#DrugCompanyPhaseTrials
1Oxycontin
PProtega
Phase 3
Epidiolex
Jazz PharmaceuticalsPhase 2
Suboxone
Merck & Co.Phase 3
Narcan
SScienture
Phase 1
DOVATO
GSKPhase 3
Alfenta
Jazz PharmaceuticalsPreclinical
Barhemsys
Tibotec Pharmaceuticals, IrelandPreclinical
Imodium
KKenvue Brands
Phase 1
Bupivacaine Hydrochloride-EPINEPHrine
UUniversity of Missouri-Columbia
Phase 1
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Phase 1[1]
- Company
- UUniversity of Missouri-Columbia